The drug industry and medical practice—the case of menopausal hormone therapy in Estonia

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

JAMA · 2002 · 15.8K citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Human Development Report

James A. Church · Journal of Government Information · 2001 · 9.2K citations

Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women

Stephen B. Hulley · JAMA · 1998 · 6.3K citations

Medicine, Endocrinology, Pharmacotherapy +17

Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative Randomized Controlled Trial. Writing Group for the Women's Health Initiative Investigators. <i>JAMA</i> 2002; 288(3): 321-333

Dr Ailsa Gebbie · Journal of Family Planning and Reproductive Health Care · 2002 · 1.2K citations · Full text

Medicine, Endocrinology, Gynecology +11

Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry

Niteesh K. Choudhry · JAMA · 2002 · 649 citations

Pharmacy, Pharmaceutical Policy, Clinical Pharmacology +8